ОСОБЕННОСТИ ХРОНИЧЕСКОЙ ЦЕРЕБРАЛЬНОЙ ВЕНОЗНОЙ НЕДОСТАТОЧНОСТИ

In the article, the effect of L-lysine escinate in 90 patients with chronic cerebral venous insufficiency (ChcVn) on the dynamics of complaints and the severity of neurological syndromes was studied. The main group consisted of 50 patients who received 2 courses of therapy with L-lysine escinate intravenously drop / stream slowly at a dose of 5 ml for 7 days, conducted on the 2nd and 30th day of observation, and 40 patients who made up the comparison group. The result revealed that treatment with L-lysine escinate leads to a significant reduction in patient complaints and improved scoring on the scales used. The safsignificantlye profile of the effect of the drug L-lysine escinate has been confirmed in the recommended doses.